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A wide range of data sources are available to study the
epidemiology of mental illness. Community surveys such
as Alex Leighton’s Stirling County Study are the gold stan-
dard for such data sources, particularly because community
surveys cover everyone, not just people seeking treatment.
However, as surveys require a lot of resources, other meth-
ods are also used, each of which has strengths and weak-
nesses. For example, medical records contain detailed
information, but this can be difficult to extract and the qual-
ity may vary. Another source entails administrative data,
typically hospital separations, physician billings, ambulatory
care visits, and drug databases. While such data require
careful analysis with the use of multivariate or propensity
score techniques to adjust for potential confounding vari-
ables, these data can be invaluable in the study of diseases
with multifactorial aetiologies.
This paper addresses how these large administrative data-
bases, or big data, can help address mental health problems
in situations where conventional clinical studies are of little
help. Patients with chronic disease are an example, given
they are often excluded from clinical trials on account of
their multiple medical and psychiatric comorbidities. This
is an important omission, as these diseases are major sources
of disability and burden worldwide. While the causes of
chronic illnesses are not fully known, a range of apparently
interrelated personal, social, economic, and environmental
factors are associated with their development. As much as
40% of chronic illness may be attributable to a small number
of modifiable risk factors like smoking, obesity, physical
inactivity, and poor nutrition.1,2 Other potentially modifiable
causes include poverty, social inequality, poor education,
and environmental factors.1,2 These wider influences are,
again, rarely considered in clinical trials.
Of relevance to Dr Leighton’s longstanding interest in the
Maritimes is that this region has generally poorer health,
lower incomes, higher unemployment, and a smaller propor-
tionate share of the national wealth than the rest of Canada.
The region also has higher rates of smoking, obesity, and
physical inactivity, which are both risk factors for and symp-
toms of socioeconomic inequity.3 As a result, Nova Scotia
has the lowest disability-free life expectancy in the country,
3 years less than the Canadian average.4
Physical and mental illnesses are closely related, and
administrative data can complement community surveys
such as Stirling County, or the Canadian Community Health
Survey, in exploring these issues further. While lacking the
rich detail of community surveys, administrative data have
advantages in terms of coverage and cost. They also can be
continuously updated. For example, the Public Health
Agency of Canada has developed case definitions for the
surveillance of mental health disorders using administrative
data across Canada.5 It is also possible to link data extracts
across databases—for example, hospital morbidity and phy-
sician billings—using encrypted or anonymized identifiers.
This offers the opportunity to track progress through the
entire health system. Of particular relevance to chronic dis-
eases, whose causes are often multifactorial, it is increas-
ingly possible to link health data to income level,
deprivation indices, and geospatial information.
Studies of administrative data have shown that people
with psychiatric disorders are twice as likely to be admitted
for physical conditions which, with appropriate primary
care, should not require inpatient treatment, including com-
plications of diabetes, cardiovascular disorders, and acute
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exacerbation of respiratory conditions.6 Canadian data also
show that people with schizophrenia have more physician
contacts for diabetes and cardiovascular disease.7 But it is
the increase in preventable and premature mortality in peo-
ple with mental illness, particularly severe mental illness,
that is of most concern. This was noted as far back as the
early 1930s when mortality rates within the major asylums
of New York were compared with mortality rates in the
general population.8 The mortality rates in these institutions
were increased for both males and females across the lifespan,
with the major causes being conditions such as cardiovascular
disease, not suicide. A similar pattern remains to this day.
Patients with severe mental illnesses such as schizophrenia,
bipolar, and delusional disorders die 15 to 20 years earlier
than the general population.9 Excess mortality from chronic
physical diseases is up to 10 times that of deliberate self-harm
yet receives far less attention than suicide.9
Canadian studies also highlight that this not a problem
restricted to patients of mental health services.10,11 In con-
trast to many studies elsewhere that are restricted to patients
of specialised psychiatric services, studies from Canada
often include people who are attending primary care for their
mental health problems. These samples are therefore more
representative of the general population given that the vast
majority of psychiatric morbidity is treated by family doc-
tors. Although the disparity in life expectancy is less than in
the United States or Australia,10 possibly related to better
universal health care and a more representative sample, 72%
of excess deaths occurred in people who had only ever
attended general practice for their psychiatric care.11
Furthermore, evidence indicates that the gap in mortality
has been widening over the last few decades despite a shift to
community-based treatment and the integration of psychia-
tric and general medical services.12,13 Some of these changes
could have been expected to reduce the level of exposure to
some mortality risks, such as infectious diseases, and
improve access to physical health care.14 At the same time,
other risks could have increased with more freedom to make
unhealthy lifestyle choices, or experience adverse social cir-
cumstances such as homelessness.14 This widening gap is
especially true of cardiovascular disease, as shown by an
increase in mortality in psychiatric patients at a time when
deaths from ischaemic heart disease in the general popula-
tion have been falling. People with mental illness have there-
fore not benefitted from preventative and public health
measures, such a smoking cessation or the promotion of
exercise, that have helped the general population.
However, lifestyle factors such as alcohol, tobacco, and
substance use, as well as diet and lack of exercise, are
unlikely to be the sole answer. For instance, the incidence
of many cancers, including melanoma, is no higher than in
the general population while mortality is greater (Figure 1).15
If lifestyle were the only cause, incidence should more
closely match mortality. Furthermore, concurrent lifestyle
would not explain the findings for a cancer such as melanoma
where childhood sun exposure is the main risk factor. Of
course, it is possible that a lower than expected cancer inci-
dence could be due to people with mental illness dying pre-
maturely from lifestyle-induced cardiovascular disease.
However, all-cause mortality remains high even after adjust-
ment for behavioural risk factors such as smoking, physical
activity, and body mass index.16
If people are no more likely to develop a disorder but are
more likely to die of it, this suggests possible issues around
treatment.17-19 These include delays in detection or initial
presentation, leading to more advanced illness at diagnosis,
or decreased access to services.17 Canadian and Australian
studies have shown that psychiatric patients are more likely
to die of cardiovascular disorders and cancer but less likely
to receive the appropriate treatment such as coronary artery
bypass grafts, surgery, or chemo/radiotherapy.17-22 Cana-
dians with psychoses are also less likely to be discharged
with guideline-consistent medication following a myocar-
dial infarction.20
Figure 1. Ratios of cancer incidence and mortality rates in male psychiatric patients compared with the general population in Nova Scotia.
La Revue Canadienne de Psychiatrie 62(3) 183
Administrative data have been used to study the long-term
effects of poor oral health in people with mental illness. This
is a particularly neglected area even though psychiatric
patients have several relevant risk factors, including diet, life-
style, and psychotropic-induced dry mouth. As a result, peo-
ple with severe mental illnesses are 3 times as likely to have
lost all their teeth compared with the general popluation.23
Poor oral health is more than just a question of aesthetics or
pain; it can also predispose to chronic physical diseases such
as myocardial infarction, stroke, and diabetes. For instance,
studies of hospital administrative data have shown that dental
disease accounts for 13% of avoidable admissions for preven-
table medical conditions in people with mental illness.6
Ways of addressing these problems include a greater
awareness among clinicians of physical symptoms, registra-
tion with a family physician, and shared mental health care.
However, many of these interventions are complex, and we
also need to consider the influence of socioeconomic or envi-
ronmental factors in determining response. Clinical trials are
less suitable for this type of evaluation as they usually exclude
patients with comorbidities, including alcohol or substance
use. Epidemiological studies are therefore vital to under-
standing these wider environmental factors so as to enable
population and health service–level interventions to address
these multiple factors. In addition, by linking prescription
data from provincial health plans, or pharmacies, to health
service use and mortality, it may be possible to study the
effects of medication in the ‘‘real world’’ throughout a drug’s
life cycle.24 By contrast, Phase 3 clinical trials provide little
information on long-term use, drug interactions, or high-risk,
complex patients who may be more susceptible to adverse
events, while Phase 4 trials are expensive to conduct. Con-
tinuous surveillance can, therefore, establish safety and effec-
tiveness as well as detect rare, but serious, adverse events.
But the uses of health administrative data extend beyond
surveillance.25 Combined with advanced analytics, these
data can also be used in the modelling and evaluation of
interventions within complex health systems. For instance,
these approaches can reveal causal relationships that would
help in prediction, signal detection, and the assessment of
real-world effectiveness across the diversity of patients in
usual medical practice.
Of course there are limitations. Administrative data are
designed for billing, rather than evaluation, and both data
quality and coverage may vary by province. Provincial drug
plans are a notable example. Where information on data
quality does exist, it primarily involves hospital admissions
or separations rather than physician billings, where most
treatment occurs. In addition, administrative databases cap-
ture data only on patients treated by medically trained prac-
titioners, not other health professionals such as psychologists
or occupational therapists. Data on all but the most severe
cases of alcohol or substance use are rarely captured. The
information is mostly restricted to demographic characteris-
tics, health service contacts, and diagnosis. Important out-
comes such as recovery, wellness, quality of life, or social
determinants of health are rarely considered, nor are the
views of patients. Finally, it can take researchers some time
to obtain permission for access to the data.
Nevertheless, administrative health data can both quan-
tify the problem and track the effects of interventions at
programme and population levels on a continuous basis at
relatively little cost. These data cover patients such as those
with multiple chronic comorbidities who are not typical of
people in clinical trials. In the future, the utility of these data
would be enhanced by linkage to medical and dental insur-
ance plans, or workers’ compensation schemes, as well as
data outside of health such as education. Big data such as
these will play an ever-increasing role in epidemiology, and
Canada is well placed to benefit from these developments.
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